Insider · CIK 0001871152

Deardorf Caren

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001871152

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$40.29	−$504K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,730 sh	$49.13	−$478K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.4K sh	$52.67	−$545K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−16.3K sh	$85.00	−$1.39M	5,925
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,925 sh	$85.00	−$504K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	$65.70	−$2.3M	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,375 sh	$66.71	−$292K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	$64.68	−$1.13M	0
2026-06-18	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,730 sh	—	—	9,730
2026-06-18	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+5,925 sh	—	—	22,225
2025-06-11	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+6,900 sh	—	—	16,300
2025-06-11	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,350
2024-06-07	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+3,400 sh	—	—	9,400
2024-06-07	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-16	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-06-16	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+6,000 sh	—	—	6,000
2022-11-30	DNTHDianthus Therapeutics, Inc. /DE/A Award	Chief Commercial Officer	AAward	+3,000 sh	$0.94	+$2,820	19,762
2022-08-01	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+75K sh	—	—	75,000
2022-06-17	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,375 sh	—	—	4,375
2022-05-31	DNTHDianthus Therapeutics, Inc. /DE/A Award	Chief Commercial Officer	AAward	+3,000 sh	$0.99	+$2,970	16,762
2022-05-17	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+50K sh	—	—	50,000
2022-03-11	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-03-11	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2022-02-15	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+75K sh	—	—	75,000
2021-09-16	DNTHDianthus Therapeutics, Inc. /DE/S Sale	Chief Commercial Officer	SSale	−6,238 sh	$6.73	−$42K	13,762
2021-09-14	DNTHDianthus Therapeutics, Inc. /DE/A Award	Chief Commercial Officer	AAward	+20K sh	—	—	20,000
2021-07-06	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Sep 14
Deardorf Caren0001628280-26-059901
SEC(opens sec.gov)
Jun 224
Deardorf Caren0001628280-26-044721
SEC(opens sec.gov)
Jun 134
Deardorf Caren0000950170-25-086269
SEC(opens sec.gov)
Jun 114
Deardorf Caren0000950170-24-071931
SEC(opens sec.gov)
Jun 214
Deardorf Caren0001209191-23-038823
SEC(opens sec.gov)
Dec 24
Deardorf Caren0000899243-22-037432
SEC(opens sec.gov)
Aug 14
Deardorf Caren0000899243-22-027264
SEC(opens sec.gov)
Jun 214
Deardorf Caren0001209191-22-038436
SEC(opens sec.gov)
Jun 64
Deardorf Caren0000899243-22-021185
SEC(opens sec.gov)

Companies

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121